In the last 30 years or so there has been increased attention on the medical uses of cannabis and its constituent chemicals. Cannabis itself contains at least 60 active cannabinoids, one of which, cannabidiol (CBD)...
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
However, evidence to date confined to kids/teens and rare and serious forms of the condition.
Background: Crohn's disease is an idiopathic inflammatory process that is occasionally associated with complications, which cause significant morbidity and mortality.
DA to decide on ProSense marketing for early-stage, low-risk breast cancer with endocrine therapy by Q1 2025.
The FDA has approved Epidiolex (cannabidiol) [CBD] oral solution, from GW Pharma, for the treatment of seizures associated with two...
Alcohol, nicotine and cannabis are among the most commonly used drugs. A prolonged and combined use of these substances can alter normal brain wiring in different ways depending on the consumed cocktail mixture.
Astellas Pharma Inc. announced dosing of the first patient in the HIGHLIGHT 1 Phase III pivotal study for fezolinetant, an investigational oral, nonhormonal compound being studied for the treatment of moderate to severe vasomotor symptoms (VMS) in women with breast cancer receiving adjuvant endocrine therapy
Patients with multiple sclerosis have long turned to complementary therapies to manage symptoms that licensed products can only partially control.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Keytruda (pembrolizumab) from Merck Sharp & Dohme for triple negative breast cancer.
